Myriad Genetics, Inc. - Common Stock (MYGN)
Frequently Asked Questions About Myriad Genetics, Inc. - Common Stock (MYGN)
Does Myriad Genetics, Inc. have partnerships with other organizations?
Yes, Myriad Genetics has established partnerships with various organizations, including academic institutions, healthcare providers, and pharmaceutical companies. These collaborations aim to advance research, enhance product offerings, and improve patient outcomes through shared expertise.
How can I contact Myriad Genetics, Inc.?
Interested parties can contact Myriad Genetics through their official website, where they provide various contact options, including phone numbers and email addresses for customer service and healthcare provider inquiries. Additionally, they maintain a presence on various social media platforms for broader engagement.
How does Myriad Genetics, Inc. contribute to personalized medicine?
Myriad Genetics is at the forefront of personalized medicine by providing genetic tests that allow healthcare providers to tailor treatment plans according to a patient’s unique genetic makeup. This approach enhances treatment efficacy and minimizes unnecessary interventions, ultimately improving patient care.
How does Myriad Genetics, Inc. ensure the accuracy of its tests?
Myriad Genetics employs rigorous validation and quality control processes to ensure the accuracy and reliability of its genetic tests. The company follows regulatory guidelines and industry best practices while continually improving test methodologies to maintain high standards.
How has Myriad Genetics, Inc. performed financially?
Myriad Genetics has experienced fluctuations in its financial performance due to various market factors and the competitive landscape of genetic testing. The company continually strives to enhance its product portfolio and reach profitability through innovative testing and strategic initiatives.
Is Myriad Genetics, Inc. publicly traded?
Yes, Myriad Genetics, Inc. is publicly traded on the Nasdaq under the ticker symbol MYGN. The company’s shares are available for purchase by individuals and institutional investors.
What are the potential implications of genetic testing for patients?
Genetic testing can have significant implications for patients, including insights into their genetic risk for certain diseases, the ability to make informed healthcare choices, and the option for family members to learn about their own risks. However, it also raises ethical and psychological considerations that must be addressed.
What does Myriad Genetics, Inc. do?
Myriad Genetics, Inc. is a molecular diagnostics company that focuses on the development and commercialization of innovative genetic tests that help determine the risk of developing certain diseases, guiding treatment decisions and improving patient outcomes. The company specializes in genetic testing for hereditary cancer and other diseases, providing healthcare providers with critical information to personalize patient care.
What is Myriad Genetics' approach to patient education?
Myriad Genetics prioritizes patient education by providing comprehensive resources and support to help patients understand their test results and the implications for their health. The company fosters communication between patients and healthcare providers to enhance the patient experience.
What is Myriad Genetics, Inc.'s mission?
Myriad Genetics’ mission is to transform patient care through the development of innovative genetic tests that enable personalized medicine. The company is committed to providing healthcare providers and patients with actionable information to make better-informed medical decisions.
What is the future outlook for Myriad Genetics, Inc.?
The future outlook for Myriad Genetics appears promising, with ongoing advancements in genetic testing technology and a growing focus on personalized medicine. The company aims to expand its test offerings, penetrate new markets, and pursue strategic partnerships to foster growth and innovation.
What is the pricing structure for Myriad Genetics' tests?
Myriad Genetics’ pricing structure varies based on the specific test and the patient's insurance coverage. The company works with healthcare providers and patients to navigate insurance reimbursement options, ensuring access to testing.
What is the significance of BRCA testing?
BRCA testing is significant as it assesses an individual's risk for developing breast and ovarian cancers due to mutations in the BRCA1 and BRCA2 genes. Identifying these mutations can guide proactive measures, such as increased surveillance or preventive surgery, significantly impacting patient management and outcomes.
What recent innovations has Myriad Genetics, Inc. introduced?
Myriad Genetics has introduced several innovative tests and technologies in recent years, including expanded genetic panels for various cancers and advancements in pharmacogenomic testing. These innovations reflect the company’s commitment to staying at the forefront of genetic research and diagnostics.
What types of tests does Myriad Genetics, Inc. offer?
Myriad Genetics offers a breadth of genetic tests, focusing primarily on hereditary cancer testing, pharmacogenomics, and women’s health. Their flagship tests include BRCA1 and BRCA2 testing for breast and ovarian cancer risk, along with tests for colorectal cancer, melanoma, and other hereditary conditions.
When was Myriad Genetics, Inc. founded?
Myriad Genetics, Inc. was founded in 1991. Since its inception, the company has pioneered advancements in genetic testing and personalized medicine, establishing itself as a leader in the field.
Where is Myriad Genetics, Inc. headquartered?
Myriad Genetics, Inc. is headquartered in Salt Lake City, Utah. The location is strategic for its access to a highly skilled workforce and proximity to research institutions.
Who are Myriad Genetics, Inc.'s primary customers?
Myriad Genetics primarily serves healthcare professionals, including oncologists, gynecologists, and primary care physicians, who utilize its genetic tests to inform patient diagnosis, treatment, and risk assessments. Additionally, the company collaborates with laboratories and health systems to expand its reach.
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 7.955
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 2:55 pm EDT on April 4th, 2025
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 726.29M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 91.30M shares outstanding.